Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Designer Drugs

"Designer Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.


This graph shows the total number of publications written about "Designer Drugs" by people in Harvard Catalyst Profiles by year, and whether "Designer Drugs" was a major or minor topic of these publication.
Bar chart showing 18 publications over 10 distinct years, with a maximum of 3 publications in 2013 and 2018
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.